Laureen shows you her proprietary “Bubbling and Highlighting Technique”
Download your Free copy of my "Medical Coding From Home Ebook" at the top right corner of this page
Help!! 
Help!!
Thanks in advance for any feedback!
I am wondering what your experience has been regarding whether or not it is appropriate to charge a patient for regenerative medicine, eg: PRP, allograft while charging the insurance for the procedure which is typically a facet injection.
I need to know what the legality around this is and what anyone else might be doing in this scenario.
Thank you!
I am new to coding for physical medicine doctors. Many of whom, see inpatients before they are and then when they transferred to a rehab floor. My question is how to discern what is the focus of their visit. Typically, these patients have either fallen and broken an leg/arm, or they’ve had a stroke or heart attack. In my opinion, these types of physicians are not treating the underlying illness or injury, but rather the residuals- difficulty walking/malaise/dysphasia/functional decline etc… My physicians list 8-10 +diagnosis and I am not sure what to list first.
If anyone can help me to better understand, I’d truly appreciate it!
Thanks!
-Kathleen
The Joint Commission unveiled a new Medication Compounding Certification (MCC) program in January with the goal of reducing the harm stemming from drug compounding and ensuring compliance with U.S. Pharmacopeial Convention (USP) and Joint Commission standards. Meanwhile, USP Chapter <800> goes into effect on July 1, 2018 and contains major changes aimed at protecting healthcare workers from exposure to hazardous drugs and materials.
Kurt Patton, MS, RPh, a former director of accreditation services for The Joint Commission and founder of Patton Healthcare Consulting in Naperville, Illinois spoke with BOAQ on the details surrounding medication compounding.